Innovent Biologics
Responsible for business cooperation, Master of Business Administration from Thunderbird School of Global Management. He has worked in Eli Lilly for nearly 24 years and has completed more than 50 different types of cooperation. 28 years of working experience in the pharmaceutical and biotechnology industries, and 20 years of business development experience.
This person is not in any offices
Innovent Biologics
2 followers
Innovent Biologics, Inc. is a China-based biopharmaceutical company. The Company's main products include PD-1 antibody; bevacizumab (Avastin) biosimilar, IBI-305; rituximab (MabThera/Rituxan) biosimilar, IBI-301; and adalimumab (Humira) biosimilar, IBI-303.